A61K 36/34
Campanulaceae
Official title: Campanulaceae (Bellflower family)
A61K36/34 (Campanulaceae) appears on 121 US grants and 185 published applications in this corpus.
Search patents in A61K- Granted patents
- 121
- Published applications
- 185
- Assignees
- 104
- Inventors
- 478
- Latest grant
- 19 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1990 | 1 | 0 |
| 1991 | 4 | 0 |
| 1992 | 3 | 0 |
| 1993 | 2 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 4 | 8 |
| 2003 | 3 | 7 |
| 2004 | 2 | 6 |
| 2005 | 3 | 5 |
| 2006 | 7 | 6 |
| 2007 | 2 | 5 |
| 2008 | 1 | 7 |
| 2009 | 1 | 3 |
| 2010 | 2 | 5 |
| 2011 | 0 | 4 |
| 2012 | 1 | 3 |
| 2013 | 2 | 4 |
| 2014 | 3 | 4 |
| 2015 | 6 | 12 |
| 2016 | 3 | 6 |
| 2017 | 8 | 7 |
| 2018 | 7 | 14 |
| 2019 | 7 | 10 |
| 2020 | 8 | 8 |
| 2021 | 9 | 4 |
| 2022 | 7 | 17 |
| 2023 | 4 | 9 |
| 2024 | 4 | 16 |
| 2025 | 8 | 10 |
| 2026 | 6 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Preparation of insoluble polysaccharides obtained from plant cell cultures in suspension for the treatment of clostridium difficile infections19 May 2026US 12,629,402 B2Abresearch Srl
- Manufacturing method for composition promoting recovery of bone fracture24 Mar 2026US 12,582,686 B2
- Eye-soothing externally-applied liquid medicine and preparation method therefor17 Feb 2026US 12,551,476 B2
- Herbal compositions and methods for treating and preventing SARS-CoV-2 virus infection17 Feb 2026US 12,551,522 B2China Medical University
- Manufacturing method for composition promoting bone density enhancement10 Feb 2026US 12,544,416 B2
- Method for preparing eye-soothing externally-applied liquid medicine and method for external application thereof13 Aug 2026US 2026/0232650 A1
- Application of Shenling Baizhu in Preparation of Medicine for Treating Neuropsychiatric Symptoms of Recovered COVID-19 Patients23 Jul 2026US 2026/0207693 A1Beijing Redsun Pharmaceutical Co.,Ltd.
- Traditional chinese medicine composition and traditional chinese medicine decoction for preventing and/or treating interstitial lung disease, and preparation method therefor and use thereof14 May 2026US 2026/0130962 A1Chongqing Academy of Chinese Materia Medica
- Herbal medicine extracts rm01 and uses and methods of preparation thereof9 Apr 2026US 2026/0097090 A1RenuMemo Therapeutics LLC
- Combination therapy of traditional chinese and modern medicine for treatment of patients with amyotrophic lateral sclerosis22 Jan 2026US 2026/0021150 A1Integrated Molecular Medicine Limited
Most cited
By later US patents
- Effervescent green tea extract formulation73US 6,299,925 B1XEL Herbaceuticals, Inc. · 2001
- Compositions and method of treating cardio-, cerebro-vascular and alzheimer's diseases and depression64US 5,589,182 A1996
- Natural composition extracted from plants used in the treatment of cancer23US 5,876,728 A1999
- Anti-fatigue and tonic agent containing wild ginseng23US 6,896,910 B22005
- Pharmaceutical composition for increasing the production of nitric oxide and IFN-γ, and process for preparation thereof18US 7,118,767 B2Jakwang Co., Ltd. · 2006